Advanced Certificate in Pharmacokinetics and Bioequivalence
-- ViewingNowThe Advanced Certificate in Pharmacokinetics and Bioequivalence is a comprehensive course that provides learners with in-depth knowledge of the fundamental concepts and applications of pharmacokinetics and bioequivalence. This course is essential for professionals working in the pharmaceutical industry, clinical research organizations, and regulatory agencies who are involved in drug development, evaluation, and approval processes.
2,259+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Advanced Pharmacokinetics: This unit will cover advanced topics in pharmacokinetics, including non-linear pharmacokinetics, pharmacokinetic interactions, and individualization of drug dosing regimens.
⢠Bioequivalence Principles: This unit will focus on the fundamental principles of bioequivalence, including the statistical and regulatory aspects of demonstrating bioequivalence.
⢠In Vitro-In Vivo Correlations: This unit will cover the use of in vitro data to predict in vivo pharmacokinetics, including the development and validation of in vitro-in vivo correlations.
⢠Biopharmaceutics Classification System: This unit will discuss the Biopharmaceutics Classification System (BCS), including its use in drug development and regulatory submissions.
⢠Bioanalytical Method Validation: This unit will cover the validation of bioanalytical methods used in pharmacokinetic and bioequivalence studies, including the regulatory requirements and best practices.
⢠Pharmacokinetic Modeling and Simulation: This unit will discuss the use of pharmacokinetic modeling and simulation in drug development, including the development and evaluation of population pharmacokinetic models.
⢠Special Populations and Pediatrics: This unit will cover the challenges and considerations in pharmacokinetics and bioequivalence studies in special populations, including pediatrics, elderly, and patients with renal or hepatic impairment.
⢠Translational Pharmacokinetics: This unit will discuss the translation of preclinical pharmacokinetic data to clinical studies, including the scaling of animal data to humans and the use of physiologically based pharmacokinetic (PBPK) modeling.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
